|Articles|May 1, 2011
- Pharmaceutical Executive-05-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2011
Sizing Up For Success
Advertisement
Articles in this issue
about 15 years ago
Malaysia: The Overlooked Emerging Marketabout 15 years ago
High-Risks to High Rewardabout 15 years ago
UK Stakeholders Have Their Say on Value-Based Pricingabout 15 years ago
Expanded Liability for Generic, Brand Manufacturers Ahead?about 15 years ago
Using Social Networks to Guide Product Spendabout 15 years ago
iDeal Tool of Sales Tradeabout 15 years ago
The Elusive Single-Point-of-Entryabout 15 years ago
Outrage Over Drug Pricesabout 15 years ago
Seeing Through the Transparency Directiveabout 15 years ago
On Tour with Merck's RobotsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5